Skip to main content
David Haslam, MD, Pediatric Infectious Disease, Cincinnati, OH, Cincinnati Children's Hospital Medical Center

DavidBruceHaslamMD

Pediatric Infectious Disease Cincinnati, OH

Associate Professor, Pediatrics, Cincinnati Children's Hospital

Dr. Haslam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Haslam's full profile

Already have an account?

Education & Training

  • University of Calgary Faculty of Medicine
    University of Calgary Faculty of MedicineClass of 1987
  • University of Calgary
    University of CalgaryBS, Cellular, Microbial, and Molecular Biology, 1984
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Infectious Diseases

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2013 - 2024
  • MO State Medical License
    MO State Medical License 1996 - 2016
  • American Board of Pediatrics Pediatric Infectious Diseases

Publications & Presentations

PubMed

Journal Articles

  • Antibiotic Exposure and Reduced Short Chain Fatty Acid Production After Hematopoietic Stem Cell Transplant  
    David B Haslam, Lee Denson, Christopher E Dandoy, Stella M Davies, Biology of Blood and Marrow Transplantation
  • Performance of the check-points check-MDR CT103XL assay utilizing the CDC/FDA antimicrobial resistance isolate bank  
    Powell EA, Haslam D, Mortensen JE, Diagn Microbiol Infect Dis, 1/1/2017
  • Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling  
    Giles DA, Moreno-Fernandez ME, Stankiewicz TE, Graspeuntner S, Cappelletti M, Wu D, Mukherjee R, Chan CC, Lawson MJ, Klarquist J, et al, Nature Medicine, 1/1/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Press Mentions

  • Are the Additives in Our Food Making Us Ill?
    Are the Additives in Our Food Making Us Ill?September 22nd, 2020
  • Trust Me I’m Not a Doctor
    Trust Me I’m Not a DoctorSeptember 16th, 2020
  • Heroes in the Race to Save Antibiotics
    Heroes in the Race to Save AntibioticsJune 9th, 2017
  • Join now to see all

Grant Support

  • An HTS Assay For Inhibitors Of C. Difficle ToxinsNational Institute Of Neurological Disorders And Stroke2009
  • Role Of MK2 Kinase In Toxin-Associated DiseaseNational Institute Of Allergy And Infectious Diseases2009
  • A Screen For Small Molecule Inhibitors Of Shiga Toxin And Ricin ActivityNational Institute Of Mental Health2008–2009
  • Discovery Of Novel Therapeutics Against Shiga And Ricin ToxinsNational Institute Of Allergy And Infectious Diseases2008
  • A Screen For Small Molecule Compounds That Inhibit Bacterial ToxinsNational Institute Of Mental Health2007–2008
  • Role Of Er-Localized Chaperones In Toxin PathogenesisNational Institute Of Allergy And Infectious Diseases2003–2006
  • Er-Localized Chaperones In Toxin PathogenesisNational Institute Of Allergy And Infectious Diseases2002
  • Glycolipids And Hemolytic Uremic SyndromeNational Institute Of Allergy And Infectious Diseases1998–2002
  • Regulation Of Globopentosylceramide ExpressionEunice Kennedy Shriver National Institute Of Child Health &Human Development1995–1996

Hospital Affiliations